Sulindac‐derived retinoid X receptor‐α modulator attenuates atherosclerotic plaque progression and destabilization in ApoE −/− mice

Volume: 176, Issue: 14, Pages: 2559 - 2572
Published: May 23, 2019
Abstract
Background and Purpose Atherosclerosis is a chronic inflammatory disease, and retinoid X receptor-alpha (RXR alpha) is an intriguing anti-atherosclerosis target. This study investigated whether and how an RXR alpha modulator, K-80003, derived from a non-steroidal anti-inflammatory drug attenuates atherosclerotic plaque progression and destabilization. Experimental Approach Our previously established ApoE(-/-) mouse model of carotid vulnerable...
Paper Details
Title
Sulindac‐derived retinoid X receptor‐α modulator attenuates atherosclerotic plaque progression and destabilization in ApoE −/− mice
Published Date
May 23, 2019
Volume
176
Issue
14
Pages
2559 - 2572
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.